These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 33513296)

  • 1. Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk.
    Müller-Nedebock AC; van der Westhuizen FH; Kõks S; Bardien S
    Mov Disord; 2021 Apr; 36(4):815-831. PubMed ID: 33513296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction: A trembling balance.
    Manini A; Abati E; Comi GP; Corti S; Ronchi D
    Ageing Res Rev; 2022 Apr; 76():101578. PubMed ID: 35114397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.
    Müller-Nedebock AC; Brennan RR; Venter M; Pienaar IS; van der Westhuizen FH; Elson JL; Ross OA; Bardien S
    Neurochem Int; 2019 Oct; 129():104495. PubMed ID: 31233840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.
    Giannoccaro MP; La Morgia C; Rizzo G; Carelli V
    Mov Disord; 2017 Mar; 32(3):346-363. PubMed ID: 28251677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plausible Role of Mitochondrial DNA Copy Number in Neurodegeneration-a Need for Therapeutic Approach in Parkinson's Disease (PD).
    Venkatesan D; Iyer M; Narayanasamy A; Gopalakrishnan AV; Vellingiri B
    Mol Neurobiol; 2023 Dec; 60(12):6992-7008. PubMed ID: 37523043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models.
    Lang M; Grünewald A; Pramstaller PP; Hicks AA; Pichler I
    Cell Mol Life Sci; 2022 May; 79(5):283. PubMed ID: 35513611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease.
    Gezen-Ak D; Alaylıoğlu M; Genç G; Şengül B; Keskin E; Sordu P; Güleç ZEK; Apaydın H; Bayram-Gürel Ç; Ulutin T; Yılmazer S; Ertan S; Dursun E
    J Alzheimers Dis; 2020; 74(1):287-307. PubMed ID: 32007957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
    Pinto M; Nissanka N; Moraes CT
    J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
    [No Abstract]   [Full Text] [Related]  

  • 10. Damage in Mitochondrial DNA Associated with Parkinson's Disease.
    Martín-Jiménez R; Lurette O; Hebert-Chatelain E
    DNA Cell Biol; 2020 Aug; 39(8):1421-1430. PubMed ID: 32397749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.
    Keeney PM; Quigley CK; Dunham LD; Papageorge CM; Iyer S; Thomas RR; Schwarz KM; Trimmer PA; Khan SM; Portell FR; Bergquist KE; Bennett JP
    Hum Gene Ther; 2009 Aug; 20(8):897-907. PubMed ID: 19374590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism.
    Inoue N; Ogura S; Kasai A; Nakazawa T; Ikeda K; Higashi S; Isotani A; Baba K; Mochizuki H; Fujimura H; Ago Y; Hayata-Takano A; Seiriki K; Shintani Y; Shintani N; Hashimoto H
    EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29371327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons.
    Grünewald A; Rygiel KA; Hepplewhite PD; Morris CM; Picard M; Turnbull DM
    Ann Neurol; 2016 Mar; 79(3):366-78. PubMed ID: 26605748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Dysfunction in Parkinson's Disease: Focus on Mitochondrial DNA.
    Buneeva O; Fedchenko V; Kopylov A; Medvedev A
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33321831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction and oxidative stress in Parkinson's disease.
    Onyango IG
    Neurochem Res; 2008 Mar; 33(3):589-97. PubMed ID: 17940895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mtDNA variation is an important component of Parkinson's disease.
    Coxhead J; Kurzawa-Akanbi M; Hussain R; Pyle A; Chinnery P; Hudson G
    Neurobiol Aging; 2016 Feb; 38():217.e1-217.e6. PubMed ID: 26639157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA
    Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia.
    Garcia-Esparcia P; Koneti A; Rodríguez-Oroz MC; Gago B; Del Rio JA; Ferrer I
    Brain Pathol; 2018 Jan; 28(1):43-57. PubMed ID: 27984680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.